Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

Author： Goldsmith David R. Scott Lesley J. Cvetković Risto S. Plosker Greg L.

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.1, 2008-01, pp. : 85-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease

By Curran Monique P. Robinson Dean M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2329-2349

Adis International

Access to resources Recommend Favorite

Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease

By Plosker Greg L.

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 807-821

Adis International

Access to resources Recommend Favorite

Correlation between Ischaemia-modified Albumin and Intermediate-density Lipoprotein in Haemodialysis Patients with End-stage Renal Disease

By Kotani K Kimura S Kinugasa E Ogata H Caccavello R Taniguchi N Gugliucci A

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1541-1545

Field House Publishing

Access to resources Recommend Favorite

Intravenous N -Acetylcysteine during Haemodialysis Reduces the Plasma Concentration of Homocysteine in Patients with End-Stage Renal Disease

By Thaha Mochammad

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 195-202

Adis International

Access to resources Recommend Favorite

High-risk End-stage Renal Disease Patients Converted from Conventional to Short Daily Haemodialysis

By He Q Chen J Zhang P Xie W Jiang H Yuan J

The Journal of International Medical Research, Vol. 34, Iss. 6, 2006-11 ,pp. : 682-688

Field House Publishing

Access to resources Recommend Favorite